Market

Income Statement

You can view the Income Statement for the last 5 years.

INCOME STATEMENT

Accretion Pharmaceuticals Ltd.

GO
Market Cap. ( ₹ in Cr. ) 67.25 P/BV 4.07 Book Value ( ₹ ) 14.87
52 Week High/Low ( ₹ ) 83/58 FV/ML 10/1200 P/E(X) 9.90
Book Closure EPS ( ₹ ) 6.11 Div Yield (%) 0.00
(₹ in Crs.)

ParticularsMar 25Mar 24Mar 23Mar 22
Months12121212
Source Of Info (AR = Annual Report, PR = Press Release)PRARARAR
FaceValue10.0010.0010.0010.00
     
     
INCOME    
Revenue From Operations [Net]57.3833.6729.3822.29
Total Operating Revenues57.3833.6729.3822.29
     
Other Income0.090.270.150.29
Total Revenue57.4733.9429.5322.58
     
EXPENSES    
Cost Of Materials Consumed43.7125.0623.6618.61
Changes In Inventories Of FG,WIP And Stock-In Trade-3.80-3.45-0.31-1.05
Employee Benefit Expenses3.672.622.471.96
Finance Costs1.441.151.081.02
Depreciation And Amortisation Expenses0.770.850.920.81
Other Expenses1.911.951.571.13
Total Expenses47.7128.1829.3922.48
     
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax9.765.760.140.10
     
Profit/Loss Before Tax9.765.760.140.10
     
Tax Expenses-Continued Operations    
Current Tax2.971.860.040.02
Deferred Tax0.000.030.000.00
Total Tax Expenses2.971.890.030.03
Profit/Loss After Tax And Before ExtraOrdinary Items6.793.880.100.08
     
Profit/Loss From Continuing Operations6.793.880.100.08
     
Profit/Loss For The Period6.793.880.100.08
     
OTHER INFORMATION    
     
EARNINGS PER SHARE    
Basic EPS (Rs.)8.489.690.000.00
Diluted EPS (Rs.)8.489.690.000.00